Related references
Note: Only part of the references are listed.Rofecoxib Analogues Possessing a Nitric Oxide Donor Sulfohydroxamic Acid (SO2NHOH) Cyclooxygenase-2 Pharmacophore: Synthesis, Molecular Modeling, and Biological Evaluation as Anti-inflammatory Agents
Atul Bhardwaj et al.
CHEMMEDCHEM (2012)
Severe acute liver injury associated with lumiracoxib
Peter I. Pillans et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Nitric Oxide: A Guardian for Vascular Grafts?
Achala de Mel et al.
CHEMICAL REVIEWS (2011)
Cyclopentane-1,3-dione: A Novel Isostere for the Carboxylic Acid Functional Group. Application to tie Design of Potent Thromboxane (A2) Receptor Antagonists
Carlo Ballatore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties
Mariangela Biava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Marie-Germaine Bousser et al.
LANCET (2011)
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2011)
Copper-Promoted Carbon-Heteroatom Bond Cross-Coupling with Boronic Acids and Derivatives
Jennifer X. Qiao et al.
SYNTHESIS-STUTTGART (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants
Manuela Ambrosio et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization
Donatella Boschi et al.
CHEMISTRY & BIODIVERSITY (2010)
Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk
G. Enrico Rovati et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Development and Biological Evaluation of a Novel Aurora A Kinase Inhibitor
Teresa Sardon et al.
CHEMBIOCHEM (2009)
Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage
Yun Jeong Lim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Current status of COX-2 inhibitors
Palwinder Singh et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs
Timothy D. Warner et al.
LANCET (2008)
Nutritionally essential fatty acids and biologically indispensable cyclooxygenases
William L. Smith
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Antagonism of thromboxane receptors by diclofenac and lumiracoxib
E. Selg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Structural and functional basis of cyclooxygenase inhibition
Anna L. Blobaum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties
Konstantin Chegaev et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs
Majella E. Lane et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Designed multiple ligands. An emerging drug discovery paradigm
R Morphy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Cyclooxygenase inhibition and cardiovascular risk
EM Antman et al.
CIRCULATION (2005)
Adverse cardiovascular effects of the coxibs
JM Dogné et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles
RR Ranatunge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor:: Alternative role in G protein-coupled receptor signaling
V Capra et al.
MOLECULAR PHARMACOLOGY (2004)
Synthesis of new N-aryl oxindoles as intermediates for pharmacologically active compounds
M Acemoglu et al.
TETRAHEDRON (2004)
A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385
SW Rowlinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Distinct functions of COX-1 and COX-2
I Morita
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Thromboxane A(2) signalling in humans: a 'tail' of two receptors
BT Kinsella
BIOCHEMICAL SOCIETY TRANSACTIONS (2001)
Share Paper
